These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21798558)

  • 21. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipid profile in children of parents with coronary artery disease.
    Kumar K; Anand NK; Janah S
    Indian Pediatr; 1979 Dec; 16(12):1107-13. PubMed ID: 541077
    [No Abstract]   [Full Text] [Related]  

  • 23. What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    McCrindle BW; Gidding SS
    N Engl J Med; 2016 Oct; 375(17):1685-1686. PubMed ID: 27783919
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for familial hypercholesterolemia in childhood.
    Gillman MW
    Am J Dis Child; 1993 Apr; 147(4):393-6. PubMed ID: 8456794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol screening in children and adolescents.
    Newman TB; Garber AM
    Pediatrics; 2000 Mar; 105(3 Pt 1):637-8. PubMed ID: 10699121
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 28. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents. The STRIP project.
    Lapinleimu J; Nuotio IO; Lapinleimu H; Simell OG; Rask-Nissila L; Viikari JS
    Atherosclerosis; 2002 Feb; 160(2):417-23. PubMed ID: 11849666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercholesterolemia in children: Why and how to screen for it?
    Girardet JP; Bocquet A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Rozé JC; Simeoni U; Turck D; Briend A; Dupont C;
    Arch Pediatr; 2018 Apr; 25(3):175-176. PubMed ID: 29548557
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal Screening for Familial Hypercholesterolemia in Children.
    Klančar G; Grošelj U; Kovač J; Bratanič N; Bratina N; Trebušak Podkrajšek K; Battelino T
    J Am Coll Cardiol; 2015 Sep; 66(11):1250-1257. PubMed ID: 26361156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholesterol: should we screen all children or change the diet of all children.
    Lloyd JK
    Acta Paediatr Scand Suppl; 1991; 373():66-72. PubMed ID: 1927531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
    Kose E; Kose M; Ozturk SI; Ozcan E; Onay H; Ozkan B
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1251-1256. PubMed ID: 32829317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment.
    Kwiterovich PO
    Arteriosclerosis; 1989; 9(1 Suppl):I111-20. PubMed ID: 2563219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic family screening for familial hypercholesterolemia in Iceland.
    Thorsson B; Sigurdsson G; Gudnason V
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):335-8. PubMed ID: 12588780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a motivational interviewing genetic counseling intervention to increase cascade cholesterol screening in families of children with familial hypercholesterolemia.
    Kruger V; Redlinger-Grosse K; Walters ST; Ash E; Cragun D; McCarthy Veach P; Zierhut HA
    J Genet Couns; 2019 Oct; 28(5):1059-1064. PubMed ID: 31273864
    [No Abstract]   [Full Text] [Related]  

  • 38. [Family study of primary hypercholesterolemia in school children--the Tsukuba Study].
    Yanagi H; Hamaguchi H; Shimakura Y; Hirano C; Takita H; Tsuchiya S; Yoshiwara C
    Nihon Koshu Eisei Zasshi; 1990 Aug; 37(8):585-92. PubMed ID: 2132386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Universal Cholesterol Screening in Childhood: A Systematic Review.
    Smith AJ; Turner EL; Kinra S
    Acad Pediatr; 2016; 16(8):716-725. PubMed ID: 27354197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.